date:Jan 05, 2013
d submit comments to FDA on how to make the final rules as beneficial and cost-effective as possible, Levitt said.
Implementation of the rules will be phased over time, and FDA officials could not pinpoint the cost to the federal government. I think we will all see the benefits substantially outweigh the cost of implementation, Taylor said.
During Friday's call with FDA officials, some journalists appeared to question whether the agency will have the necessary resources to implement the rules.